| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/15.3.319 |
| P698 | PubMed publication ID | 3846592 |
| P2093 | author name string | Johnson M | |
| Keighley MR | |||
| Burdon DW | |||
| Ambrose NS | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Clostridium difficile | Q310543 |
| feces | Q496 | ||
| P304 | page(s) | 319-326 | |
| P577 | publication date | 1985-03-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile. | |
| P478 | volume | 15 |
| Q70194344 | Cefotaxime i.v. versus oral neomycin-erythromycin for prophylaxis of infections after colorectal operations |
| Q43167639 | Cefotetan: a second-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society |
| Q39525936 | Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration |
| Q42771516 | Changing prophylactic antibiotic protocol for reducing Clostridium difficile-associated diarrhoeal infections |
| Q24531456 | Clostridium difficile associated diarrhoea: diagnosis and treatment |
| Q33732202 | Clostridium difficile colitis after kidney and kidney-pancreas transplantation. |
| Q36411213 | Clostridium difficile in urology |
| Q30753294 | Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy |
| Q36640296 | Clostridium difficile: clinical disease and diagnosis |
| Q36162144 | Comparative analysis of the fecal bacterial community of five harbor seals (Phoca vitulina). |
| Q33702001 | Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice |
| Q47367243 | Diarrhea and weight loss after bone marrow transplantation in children |
| Q36505208 | Effects of ceftriaxone on faecal flora: analysis by micromorphometry |
| Q37098178 | Effects of treatment with antimicrobial agents on the human colonic microflora |
| Q35733944 | Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: risk of administering IV antibiotics |
| Q35134579 | Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis |
| Q44582964 | Hospital-acquired Clostridium difficile diarrhoea and herd immunity |
| Q37981695 | Impact of antimicrobial agents on human intestinal microflora |
| Q39850623 | In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics |
| Q72639671 | Intravenous teicoplanin does not prevent Clostridium difficile associated diarrhea |
| Q35941385 | Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not. |
| Q34756288 | Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam |
| Q26767079 | Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection |
| Q46608480 | Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment |
| Q40912926 | Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly |
| Q40283985 | Suppression of colonic microflora by cefoperazone and evaluation of the drug as potential prophylaxis in bowel surgery |
| Q62686173 | Systematic review of the cost-effectiveness of preoperative antibiotic prophylaxis in reducing surgical-site infection |
| Q68213793 | The cephalosporins |
| Q37988126 | Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary? |
Search more.